Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Equol is a non-steroidal estrogen produced in the gut from the metabolism of the soy isoflavone daidzein by certain intestinal bacteria. Its use to support the vaginal body system is primarily grounded in scientific research, particularly for menopausal and postmenopausal women experiencing symptoms of vaginal atrophy and dryness due to declining estrogen levels. Several clinical studies and reviews have investigated equol’s selective estrogen receptor modulator (SERM) activity, which allows it to bind estrogen receptors and mimic some of estrogen’s beneficial effects on vaginal tissues without the risks associated with traditional hormone therapy.

Randomized controlled trials have shown that supplementation with S-equol can improve subjective vaginal symptoms such as dryness, irritation, and discomfort, and may also positively influence the vaginal maturation index (VMI), a cytological marker of estrogen effect on the vaginal epithelium. However, there is variability in individual response, largely because only about 30-50% of people naturally harbor the gut bacteria necessary to produce equol from dietary soy. Proprietary equol supplements bypass this limitation by providing the active compound directly.

Despite promising data, the body of evidence remains moderate and somewhat limited by sample size, study design heterogeneity, and variations in dosing. Thus, while the scientific rationale and early clinical results are supportive, more large-scale, long-term trials are needed for conclusive guidance. Currently, the evidence level is best rated as moderate (3/5) for supporting vaginal health.

More about equol (proprietary)
More about Vagina

Other ingredients that support Vagina

Other body systems supported by equol (proprietary)

Products containing equol (proprietary)